These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37151549)

  • 1. Development of a Cell-Based AlphaLISA Assay for High-Throughput Screening for Small Molecule Proteasome Modulators.
    Staerz SD; Lisabeth EM; Njomen E; Dexheimer TS; Neubig RR; Tepe JJ
    ACS Omega; 2023 May; 8(17):15650-15659. PubMed ID: 37151549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syrosingopine Enhances 20S Proteasome Activity and Degradation of α-Synuclein.
    Sadahiro Y; Nishimura S; Hitora Y; Tsukamoto S
    J Nat Prod; 2024 Mar; 87(3):554-559. PubMed ID: 37938154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.
    Jones CL; Njomen E; Sjögren B; Dexheimer TS; Tepe JJ
    ACS Chem Biol; 2017 Sep; 12(9):2240-2247. PubMed ID: 28719185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluspirilene Analogs Activate the 20S Proteasome and Overcome Proteasome Impairment by Intrinsically Disordered Protein Oligomers.
    Fiolek TJ; Keel KL; Tepe JJ
    ACS Chem Neurosci; 2021 Apr; 12(8):1438-1448. PubMed ID: 33788542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecule Modulation of Proteasome Assembly.
    Njomen E; Osmulski PA; Jones CL; Gaczynska M; Tepe JJ
    Biochemistry; 2018 Jul; 57(28):4214-4224. PubMed ID: 29897236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroquinazolines enhance 20S proteasome activity and induce degradation of α-synuclein, an intrinsically disordered protein associated with neurodegeneration.
    Fiolek TJ; Magyar CL; Wall TJ; Davies SB; Campbell MV; Savich CJ; Tepe JJ; Mosey RA
    Bioorg Med Chem Lett; 2021 Mar; 36():127821. PubMed ID: 33513387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of Intrinsically Disordered Proteins by the NADH 26S Proteasome.
    Tsvetkov P; Myers N; Adler J; Shaul Y
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33297334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.
    Mittenberg AG; Kuzyk VO; Shabelnikov SV; Gorbach DP; Shatrova AN; Fedorova OA; Barlev NA
    Cell Cycle; 2018; 17(14):1745-1756. PubMed ID: 30009671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-Terminus of the PSMA3 Proteasome Subunit Preferentially Traps Intrinsically Disordered Proteins for Degradation.
    Biran A; Myers N; Steinberger S; Adler J; Riutin M; Broennimann K; Reuven N; Shaul Y
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
    Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
    Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of ornithine decarboxylase by the mammalian and yeast 26S proteasome complexes requires all the components of the protease.
    Elias S; Bercovich B; Kahana C; Coffino P; Fischer M; Hilt W; Wolf DH; Ciechanover A
    Eur J Biochem; 1995 Apr; 229(1):276-83. PubMed ID: 7744041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Disordered Landscape of the 20S Proteasome Substrates Reveals Tight Association with Phase Separated Granules.
    Myers N; Olender T; Savidor A; Levin Y; Reuven N; Shaul Y
    Proteomics; 2018 Nov; 18(21-22):e1800076. PubMed ID: 30039638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of protein degradation: an odyssey with ODC.
    Kahana C; Asher G; Shaul Y
    Cell Cycle; 2005 Nov; 4(11):1461-4. PubMed ID: 16205122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating the 20S proteasome ubiquitin-independent degradation pathway.
    Ben-Nissan G; Sharon M
    Biomolecules; 2014 Sep; 4(3):862-84. PubMed ID: 25250704
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li Y; Sun D; Yan X; Wang Z; Zhang X
    Bio Protoc; 2021 Apr; 11(7):e3967. PubMed ID: 33889661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.
    Opoku-Nsiah KA; Gestwicki JE
    Transl Res; 2018 Aug; 198():48-57. PubMed ID: 30244692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ubiquitin-independent protein degradation in proteasomes].
    Buneeva OA; Medvedev AE
    Biomed Khim; 2018 Mar; 64(2):134-148. PubMed ID: 29723144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disordered Substrates of the 20S Proteasome Link Degradation with Phase Separation.
    Guharoy M; Lazar T; Tompa P
    Proteomics; 2018 Nov; 18(21-22):e1800276. PubMed ID: 30070766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.
    Anchoori RK; Khan SR; Sueblinvong T; Felthauser A; Iizuka Y; Gavioli R; Destro F; Isaksson Vogel R; Peng S; Roden RB; Bazzaro M
    PLoS One; 2011; 6(8):e23888. PubMed ID: 21909374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution.
    Ukmar-Godec T; Fang P; Ibáñez de Opakua A; Henneberg F; Godec A; Pan KT; Cima-Omori MS; Chari A; Mandelkow E; Urlaub H; Zweckstetter M
    Sci Adv; 2020 Jul; 6(30):eaba3916. PubMed ID: 32832664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.